EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Chronic Obstructive Pulmonary Disease and the Airway Microbiome: What Respirologists Need to Know

Don D Sin

Tuberculosis and Respiratory Diseases · 01.07.2023 · 86 (3) · 166-175

DOI: 10.4046/trd.2023.0015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Tuberculosis and Respiratory Diseases, erschienen am 01.07.2023. Verfasst von Don D Sin. Beteiligte Einrichtung: Center for Heart Lung Innovation, St. Paul's Hospital and Division of Respiratory Medicine, University of British Columbia, Vancouver, BC, Canada. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: DISARM trial.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. The lower airways contain a rich and diverse microbiome, which may play a significant regulatory role in both health and disease. In COPD, the microbiome becomes perturbed, causing dysbiosis. Increased representation of members in the Proteobacteria phylum and certain members in the Firmicutes phylum has been associated with increased risk of exacerbations and mortality. Therapies such as inhaled corticosteroids and azithromycin may modulate the airway microbiome or its metabolites in patients with COPD. This paper provides an up-to-date overview of the airway microbiome and its importance in the pathophysiology of COPD and as potential therapeutic target in the future.

Schlagwörter

Stichwörter der Autor:innen

Airway MicrobiomeChronic Obstructive Pulmonary DiseaseDysbiosisSequencing

Autor:innen und Institutionen

  • Center for Heart Lung Innovation, St. Paul's Hospital and Division of Respiratory Medicine, University of British Columbia, Vancouver, BC, Canada.

Förderung

  • DISARM trial

Zitieren

APA

Sin, D. D. (2023). Chronic Obstructive Pulmonary Disease and the Airway Microbiome: What Respirologists Need to Know. Tuberculosis and Respiratory Diseases, 86(3), 166-175. https://doi.org/10.4046/trd.2023.0015

Vancouver

Sin DD. Chronic Obstructive Pulmonary Disease and the Airway Microbiome: What Respirologists Need to Know. Tuberculosis and Respiratory Diseases. 2023;86(3):166-175. doi:10.4046/trd.2023.0015

BibTeX
@article{Sin2023,
  author = {Sin, Don D},
  title = {Chronic Obstructive Pulmonary Disease and the Airway Microbiome: What Respirologists Need to Know},
  journal = {Tuberculosis and Respiratory Diseases},
  year = {2023},
  volume = {86},
  number = {3},
  pages = {166--175},
  doi = {10.4046/trd.2023.0015}
}
Kostenlos starten →